BS
Bhatia Sangeeta N.
Director
BoardF
€738,219
▼ Sales (10 ops.)
Insider track record
Board DirectorNot enough buy signals with a settled T+90 horizon to measure a track record yet.
Browse the detailed record of transactions filed by Bhatia Sangeeta N., Director. Director active across 2 companies, notably Vertex Pharmaceuticals INC / MA. Aggregated, 18 disclosures have been logged. Split: 0 buy · 10 sells. Total volume traded: €738k. History available since 1 May 2021. The latest transaction was filed on 13 February 2026 (Cession). Regulator: SEC (Form 4). The full history is free.
Companies and markets linked to Bhatia Sangeeta N.
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
Declarations18 total
266 shares@ US$500.0055.9% of flowCommon StockSEC:0000875320-26-000062:0
266 shares@ US$386.69100.0% of flowCommon StockSEC:0000875320-25-000222:0
796 shares0Common StockSEC:0000875320-25-000173:0
646 shares@ US$152.748.3% of flowCommon StockSEC:0000875320-24-000211:0
1,292 shares@ US$152.7416.8% of flowCommon StockSEC:0000875320-24-000204:0
1,001 shares0Common StockSEC:0000875320-24-000117:0
243 shares@ US$375.008.0% of flowCommon StockSEC:0001209191-23-053175:0
242 shares@ US$360.007.7% of flowCommon StockSEC:0001209191-23-052622:0
242 shares@ US$345.517.1% of flowCommon StockSEC:0000899243-23-018043:0
1,168 shares0Common StockSEC:0001209191-23-026991:0
621 shares@ US$310.0018.1% of flowCommon StockSEC:0000899243-22-034249:0
45 shares@ US$290.181.2% of flowCommon StockSEC:0000899243-22-028250:0
99 shares@ US$276.652.5% of flowCommon StockSEC:0000899243-22-027386:0
40 shares@ US$255.400.0000% mcap3.0% of flowCommon StockSEC:0000899243-22-016638:0
1,449 shares0Common StockSEC:0000899243-22-016337:0
1,907 shares@ US$125.710.0002% mcap67.3% of flowCommon StockSEC:0000899243-22-014549:0
285 shares@ US$208.964.7% of flowCommon StockSEC:0001209191-21-038182:0
1,842 shares0Common StockSEC:0001209191-21-029837:0
About Bhatia Sangeeta N.
Bhatia Sangeeta N. is Administrateur at Vertex Pharmaceuticals INC / MA and VERTEX PHARMACEUTICALS INC / MA on the XNAS market. She has 18 filings in total, and across the recent filings held, sales amount to EUR 738219, with a date range from 2021-05-04 to 2026-02-18 and a dominant transaction nature indicated as Cession.